Myeloid-Derived Suppressor Cells as Immunomodulators in Pediatric Inflammatory Bowel Disease
Phase: Recruiting
Condition(s): Crohn’s Disease , Ulcerative Colitis
What Is the Purpose of This Study?
This is a prospective, observational study to determine the role of myeloid-derived suppressor cells in children newly diagnosed with Crohn’s disease or ulcerative colitis.
Who Can Take Part in This Study?
Patients undergoing colonoscopy for evaluation of GI symptoms.
What Will Happen During This Study?
- After being scheduled for a colonoscopy, participants will be screened for eligibility.
- After screening they will undergo the colonoscopy where additional data, blood samples, biopsies, and stool samples will be collected.
- The duration of study participation is 3 years, and additional samples will be collected at each follow up colonoscopy.
Principal Investigator
Discover More Research
Explore additional studies relating to Gastroenterology, Hepatology & NutritionYour Might Also Be Interested In
Research and Clinical Care: How They Work Together to Treat Children
In this 700 Children's blog post for parents, Nationwide Children's highlights how clinical research and clinical care work together as a key part of our strategic plan to achieve the best outcomes for children. Before delving into these elements work together, the post covers the basics of clinical research.
Stay Updated With Clinical Research. Follow @NCHClinicalResearch on Instagram!
Parents and caregivers can learn more about clinical research on our Instagram channel, @NCHClinicalResearch. You can be part of the clinical research that moves us forward in our journey to best outcomes for all children, everywhere.
Gastroenterology, Hepatology & Nutrition
Our diagnostic and therapeutic capabilities are some of the most advanced in the world. From rumination syndrome to gastroparesis to food allergies or constipation, we are blazing the trail to provide the best possible outcomes for all patients.